Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-26-060784
Filing Date
2026-05-26
Accepted
2026-05-26 08:02:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea029212303-424b3_kazia.htm 424B3 27819
2 GRAPHIC ea029212303_img1.jpg GRAPHIC 8452
  Complete submission text file 0001213900-26-060784.txt   40888
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-292303 | Film No.: 261015988
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)